Top Markets
Coin of the day
Arctic Bioscience AS Arctic Bioscience AS

Arctic Bioscience AS

ABS
株式のランク #33055
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
株価
$0.3144463
時価総額
$8.48M
変化(1日)
0.00%
変化(1年)
-2.55%
NO
取引 Arctic Bioscience AS (ABS)

カテゴリー

Arctic Bioscience AS(ABS)の配当利回りの履歴
Arctic Bioscience AS(銘柄コード: ABS)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Arctic Bioscience AS(ABS)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)